Ruiwen Zhang Center for Drug Discovery University of Houston 3455 Cullen Blvd. Houston, TX 77204 USA
Masayoshi Yamaguchi Cancer Biology Program University of Hawai‘i Cancer Center Honolulu, HI USA
Rajesh Agarwal Pharmaceutical Sciences Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Denver Aurora, CA USA Biography
Biography of Rajesh Agarwal
Dr. Rajesh Agarwal is a Professor and Vice Chairman of Pharmaceutical Sciences Skaggs School
of Pharmacy and Pharmaceutical Sciences at the University of Colorado, USA. His research
interests lie in Cancer Pharmacology: chemoprevention of cancer by natural and synthetic
agents; Cancer models: skin prostate, breast, lung, colon, bladder, pancreas, and head &
neck; Cancer Biology: Oncogenes and tumor suppressor genes, cell cycle and apoptosis
modulation, mitogenic and anti-apoptotic signaling, EMT, cancer stem cells, cancer cell
metabolism and Warfare vesicants: Cutaneous and ocular injuries by vesicants, and rescue by
natural and synthetic agents.
Nouri Neamati Department of Medicinal Chemistry University of Michigan Ann Arbor, MI USA Biography
Biography of Nouri Neamati
Dr. Nouri Neamati is a John G. Searle Professor of Medicinal Chemistry at the University Of
Michigan College Of Pharmacy. He obtained his Ph.D. in biomedical sciences from the
University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center,
Houston. He was a postdoctoral and a research fellow at the National Institutes of Health
(1995-200). Dr. Neamati later joined the University of Southern California, rising to the rank of
professor in 2011. He is also a recipient of numerous awards, including the NIH Technology
Transfer Award in 2000, STOP CANCER Award in 2001, GlaxoSmithKline Drug Discovery Award
in 2002, BCRP and LCRP Concept Awards from the Department of Defense (DOD) in 2005 and
Paul Workman Division of Cancer Therapeutics, Cancer Research UK Cancer Therapeutics Unit Cancer Research UK Centre for Cancer Therapeutics The Institute for Cancer Research Surrey England, UK Biography
Biography of Paul Workman
Prof. Paul Workman is a Chief Executive and President of The Institute of Cancer Research
(ICR). Prof. Workman is a passionate advocate of personalized molecular medicine and is an
enthusiastic practitioner of multidisciplinary cancer drug discovery and development
approaches to ‘drugging the cancer genome’. He has established and successfully led drug
discovery project teams. Professor Workman’s personal and collaborative research utilizes
molecular pharmacology and chemical biology approaches, including high-throughput and
genome-wide as well as hypothesis- driven strategies, to interrogate cancer biology, identify
and validate new drug targets, discover and develop chemical tools and drugs acting on these
targets, identify predictive and mechanism of action biomarkers, and elucidate mechanisms of
drug sensitivity of resistance.
Beverly A. Teicher Molecular Pharmacology Branch National Cancer Institute Bethesda, MD USA Biography
Biography of Beverly A. Teicher
Dr. Beverly A. Teicher is a Chief of the Molecular Pharmacology Branch at NCI, since early 2011.
Her team focuses on target and drug discovery for rare and recalcitrant cancers such as
sarcoma and small cell lung cancer. She completed her PhD in Bioorganic Chemistry from the
Johns Hopkins University and received her postdoctoral training at Yale University School of
Medicine. She joined Dana-Farber Cancer Institute as an Assistant Professor of Pathology and
rose to Associate Professor of Medicine and Radiation Therapy, Harvard Medical School at
Dana-Farber Cancer Institute and Joint Center for Radiation Therapy. She later joined Cancer
Drug Discovery at Lilly Research Laboratories where she founded and chaired the Tumor
Microenvironment Action Group.
Thomas W. Grunt Division of Oncology, Department of Medicine I Medical University Vienna (MUV) Vienna Austria Biography
Biography of Thomas W. Grunt
Dr. Grunt obtained a doctorate (Ph.D.) in Cell Biology from the University of Salzburg, Austria. Dr. Grunt also holds a Master of Science in Experimental Biology from the University of Salzburg. Currently he is also an Associate Professor in the Medical University of Vienna, Austria. He has published more than 80 scientific publications and is a named inventor of several U.S patents. Dr. Grunt received several awards from the International Society of Differentiation (ISD), the Austrian Association of Clinical Oncology and from the Austrian Society of Hematology and Oncology. He is member of the American Association of Cancer Research (AACR), the European Association of Cancer Research (EACR), the International Society of Differentiation (ISD), the International Society of Cancer Metabolism (ISCaM), and the Union for International Cancer Control (UICC).
M.S. Sheikh Department of Pharmacology SUNY Upstate Medical University Syracuse, NY USA Biography
Biography of M.S. Sheikh
Dr. M. Saeed Sheikh is a professor in the Department of Pharmacology at the State University of
New York, Upstate Medical University, Syracuse, New York, USA. His research activities are
focused on the development of tumor markers and targets for cancer therapy. Dr. Sheikh is also
involved in a research to elucidate the molecular mechanisms, regulating cell death, and
survival signaling in normal and cancer cells to better understand the processes of cancer
development and progression and to develop novel, more efficacious and less toxic anticancer
agents along with the investigation in a related area of cellular responses to genotoxic, ER and
Section: Non-coding RNAs
Michele Caraglia Department of Precision Medicine University of Campania "L. Vanvitelli" Naples Italy Biography
Biography of Michele Caraglia
Dr. Caraglia is a Full Professor of Biochemistry at the School of Medicine of the University of Campania “L.
Vanvitelli” in Naples (Italy) (UniCampania). He has served as President of the Italian Association of Cell
Cultures and Coordinator of the Signal Transduction and Nucleotides Sequencing Laboratory
at the Department of Precision Medicine at UniCampania. He is an author of more than 460 articles on
internationally peer-reviewed journals with a Scopus H index of 60, author of several
internationally issued patents. He has also served as the Editorial Board member of several international peer-reviewed
Journals. His research activity is focused on non coding RNAs as therapeutics and diagnostics and on the
delivery of drugs in tumours through the use of nanocarriers.
Section: Translational Immunotherapy
Aysegül Ilhan-Mutlu Department of Medicine Medical University of Vienna Vienna Austria Biography
Biography of Aysegül Ilhan-Mutlu
Dr. Ilhan-Mutlu is presently serving as the director of the Gastroesophageal Tumors Unit” of the Department of Oncology, MUV. She was born in 1984 and graduated from Medical University. Her PhD is focused on the characterization of the hypothetical gene. She started her residency in internal medicine at the department of Oncology. She received “Transitional Research Grant’’ of the European Society of Medical Oncology and performed a Postdoctoral stay at the German Cancer Research Center.
Section: Chemistry in Cancer Drug Discovery
Nadia H. Metwally Chemistry department Cairo University Giza Egypt
Section: Neuro-Oncology and Glioblastoma
Valerio Nardone Department of Precision Medicine University of Campania “L. Vanvitelli” Naples Italy Biography
Biography of Valerio Nardone
Dr. Valerio Nardone graduated in Medicine and Surgery from the University of Siena. He started the Residency School of Radiation Oncology and specialized in clinical management of cancer patients, performing both chemotherapy and radiotherapy. He obtained a Master’s Degree in Radiotherapy and new drugs: biology and clinic at Brescia University. He is working as a Researcher Type B (Tenure-track for Associate Professor) at University of Campania “L. Vanvitelli” in Naples. He is an author and co-author of more than 54 papers in peer-reviewed journals, as well oral communications and posters in international and national congresses. Dr. Nardone’s contribution to radiotherapy and oncology focuses on different diseases, such as brain cancer, lung cancer, prostate cancer and gastrointestinal cancer.
Section: Oncology-Virology Interface
Muhammad I. Qadir Institute of Molecular Biology and Biotechnology Bahauddin Zakariya University Multan Pakistan Biography
Biography of Muhammad I. Qadir
Dr. Qadir has developed a new cost-effective and convenient method for diagnosis of
cancer named as “Qadir test”. Dr. Qadir has also invented two anti-HIV drugs that may
be used as prophylaxis or for the treatment of AIDS, especially for Pakistani’s patients.
Dr. Qadir has worked to evaluate the pharmacological activities of local plants. He has
established use of many local plants for cancer, jaundice/hepatitis, hypertension,
asthma, diabetes, spasm, ulcer, fever, diarrhea, and infectious diseases of bacterial and
fungal origin. Dr. Qadir has also worked on the isolation and structure elucidation of
bioactive substances from medicinal plants and has resulted in the discovery of several
new/novel natural compounds. Dr. Qadir has patents for Preparations containing
locally isolated bacteriophages (Qadirphages) with their antibacterial activity. Dr.
Qadir has increased the efficacy of many drugs with the use of nanotechnology and
polymer-technology. Dr. Qadir has identified different biological and pharmacological
pathways which are important for diagnosis and management of different diseases. Dr.
Qadir has more than 190 publications, making an impact factor more than 100, and
supervision of 02 PhD and 35 M Phil theses.
Section: Molecular Oncology and Genomics
S.K. Srivastava University of South Alabama United States Biography
Biography of S.K. Srivastava
Dr. Sanjeev K Srivastava is an Assistant Professor in the Department of Pathology, University of
South Alabama, Mobile, Al, USA. He also holds joint appointment at Mitchell Cancer Institute,
AL, USA. Dr. Srivastava received his Ph.D. in Human Genetics in 2007, and completed his post-
doctoral trainings at the Semmelweis Medical University, Budapest, Hungary and USAMCI. Dr.
Srivastava is engaged in a number of research programs that encompass the areas of breast
cancer, pancreatic cancer, prostate cancer, ovarian cancer and melanomas, to identify novel
deregulated genes and dissect their underlying regulatory pathways and functional significance.
He is well trained in small animal surgeries, non-invasive imaging, micro-ultrasound, 3D tumor
models, novel cell line development among several others. He has published more than 45
international peer-reviewed articles, authored 6 book chapters, and more than 45 abstracts. His
research has been highly cited and he is a recipient of an international patent “Methods and
compositions for the diagnosis, classification, and treatment of cancer. He was funded by
NIH/NCI as a PI for two Small Business Innovation Research (SBIR) Phase I grants. In addition,
he serves as a co-Investigator on two funded NIH/NCI R01 grants. Few other grant applications
are pending on which he is a Co-Investigator.
Section: Cancer Genomics and Epigenetics
Panagiotis J. Vlachostergios Department of Medicine Weill Cornell Medicine New York, NY USA Biography
Biography of Panagiotis J. Vlachostergios
Dr. Panagiotis J. Vlachostergios MD PhD is an Assistant Professor in the Department of Medicine, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY, USA. He received his Ph.D. in Cancer Biology in 2013. He has published more than 70 international peer-reviewed articles, and authored several book chapters and abstracts. His research has been highly cited, and he is a recipient of prestigious awards from the American Society of Clinical Oncology, European Society of Medical Oncology, Society for Translational Oncology, American Federation for Medical Research, Bladder Cancer Advocacy Network, and others. He serves as an investigator on CDMRP-funded and industry-sponsored clinical studies
Section: Cancer Genomics and Epigenetic
Ning Wang School of Chinese Medicine The University of Hong Kong Pok Fu Lam Hong Kong Biography
Biography of Ning Wang
Dr. Wang Ning, received his bachelor degree in biochemistry in Sun Yat-Sen University (2006, China), Mphil degree in pharmaceutical science in Sun Yat-Sen University (2008, China) and PhD degree in pharmacology in the University of Hong Kong (2012, Hong Kong) and continued his post-doctoral training in the same University. He is now Assistant Professor in School of Chinese Medicine. Since 2006, Dr. Wang has published more than 100 international peer-reviewed papers and over 50 abstracts on conference proceedings in the field of pharmacology of natural products and Traditional Chinese Medicine. He serves in editorial boards of BMC complementary and alternative medicine, World Journal of Stem Cells and Frontiers in Pharmacology. He is the member of European Association of Cancer Research.
Section: Molecular and Translational Oncology
Chuan Xu University of Electronic Science and Technology of China Chengdu China Biography
Biography of Chuan Xu
Dr. C. Xu received his Doctoral degree from the Third Military Medical University (TMMU), China. Following his clinical and research training in internal medicine and preventive medicine at TMMU. He completed a postdoctoral research fellowship in cancer stem cell research at the Institute of Pathology and Southwest Cancer Center, Southwest hospital, TMMU. He is currently a Professor of Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China. His research interests include the self-renewal mechanism of cancer stem cell, tumor microenvironment, protein posttranslational modifications in signaling and immune regulation of cancer. He has published more than 30 papers and gained strong expertise and experience in studying protein-protein interaction and signal transduction. Dr. Xu has provided numerous services to the scientific community and beyond, his current services include the members of the Committee of Neoplastic Supportive Care, Chinese Anti-cancer Association and Experts Committee on Education for Cancer Patients, Chinese Society of Clinical Oncology.
Editorial Board Members
Jessie L.-S. Au Ohio State University Columbus, OH USA
Joseph J. Barchi, Jr Center for Cancer Research National Cancer Institute Frederick, MD USA
Davide Barreca Dipartimento di Scienze chimiche, biologiche, farmaceutiche e ambientali Università di Messina Messina Italy Biography
Biography of Davide Barreca
Davide Barreca is an Assistant Professor of biochemistry at the University of Messina. He specializes in enzyme modulation by natural compounds, inhibition of protein aggregation and activation of signal apoptotic cascade. Most of his research projects concentrate on separation and identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of their health promoting or cytotoxicity properties on cell culture. He is author of over 90 papers in peer-reviewed journals, 30 chapters in books, and 70 conference proceedings and reviewer of over 40 international scientific journals.
Przemyslaw Bozko Department of Internal Medicine Eberhard Karls University of Tubingen Tubingen Germany Biography
Biography of Przemyslaw Bozko
Przemyslaw Bozko received his Ph.D. from the University of Gdansk,
Poland in 2003. After several postdocs he became the Lab head of the
Dept. Internal Medicine at Tübingen University Hospital, Tübingen, Germany since 2012. His research interests include interactions between
tumor suppressors and oncogenes, during tumor formation and
M. Breccia Hematology, Department of Translational and Precision Medicine University of Rome “Sapienza” Rome Italy Biography
Biography of M. Breccia
Dr. Massimo Breccia is assistant physician at Sapienza University of Rome, Azienda Policlinico Umberto I. His scientific interests and publications as author or co-author (more than 300 papers in peer reviewed journals) are mainly focused on biological and clinical aspects of acute and chronic myeloid leukemias and myelodysplastic syndromes. He is a peer-reviewer for several journals such as Blood, Haematologica, Leukemia Research, British Journal of Haematology, etc and member of editorial board of 5 journal (Leukemia Research, Leukemia Research and Treatment, Hematology Reviews, etc).
He is a member of SIE, SIES, EHA and participates as study coordinator in several clinical trials for CML, AML and MDS. He is secretary of GIMEMA QoL Working Party.
Michael P. Carty Centre for Chromosome Biology National University of Ireland Galway City Ireland
Jianyuan Chai Baotou Medical College Inner Mongolia University of Science and Technology Baotou China Biography
Biography of Jianyuan Chai
Dr. Chai received his Ph.D. from the City University of New York in 1998 and completed his postdoctoral
training at Harvard University in 2001. Then he served the Department of Veterans Affairs of the USA as
a Principal Investigator (2002-2016), in affiliation with the University of California in Irvine. Currently, he
is a professor at Baotou Medical College, Inner Mongolia University of Science and Technology. He has
published dozens of science articles in a broad field, from zoology to cancer biology. He has been a
member of AGA, AHA, and ASBMB, and the editorial board of multiple journals.
Lydia W.T. Cheung School of Biomedical Sciences The University of Hong Kong Pokfulam Hong Kong Biography
Biography of Lydia W.T. Cheung
Dr. Cheung is an assistant professor in the School of Biomedical Sciences, University of Hong Kong. The focus of her research is functional characterization of genomic abnormalities in cancers (with a goal of ultimately devising the optimal therapeutic strategies for cancer patients). Her research revolutionizes the concept underlying precision cancer therapy (where mutations of the same cancer gene may have different functional impact and confer sensitivity to different drugs). She has published in Cancer Cell, Cancer Discovery, Cancer Research, Nature Communications, Genome Research, etc.
Silvio De Flora Department of Health Sciences University of Genoa Genoa Italy Biography
Biography of Silvio De Flora
MD in 1966. Assistant Professor in 1966, Full Professor in 1975, and Professor Emeritus in 2012 at the University of Genoa (Italy). Director of the Institute of Hygiene and Preventive Medicine (1986-1998) and Department of Health Sciences (1999-2005, 2010-2012). Author of 465 full length papers, 310 of which available in PubMed, cited more than 14,000 times. He collaborated with 150 laboratories all over the world. Member of the editorial board of 16 international journals. Principal investigator in a number of research projects, 10 of which awarded by the US NIH/NCI. He received several awards, among which the honor from MSU (2002), the Sobels Award (2005), and dedication of ICMAA (Brazil, 2010).
William A. Denny Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand
Lynn Ferguson Faculty of Medical & Health Sciences, Discipline of Nutrition University of Auckland Auckland New Zealand Biography
Biography of Lynn Ferguson
Prof Ferguson obtained a D. Phil. (Oxon,) from the University of Oxford. On her return to New Zealand, she developed a linkage with some anticancer drug developer, who were developing the Auckland Cancer Society Research Centre, based in the University of Auckland, New Zealand. Lynnette had become interested in applying her genetics training to an understanding of adverse genetic effects of novel drugs. She joined the Cancer Research Centre to set up the Centre for Mutagen Testing, which still functions to test anticancer drugs, novel pharmaceutical products and occupational situations as caner hazards in New Zealand. Her studies on causes of cancer have led to a significant amount of work on the New Zealand diet, and she maintains a dual interest in drugs and nutrients in the treatment and cause of cancer.
Tong-Chuan He Department of Surgery The University of Chicago Medical Center Chicago, IL USA
Chuanshu Huang Nelson Institute of Environmental Medicine New York University School of Medicine NY USA Biography
Biography of Chuanshu Huang
Chaunshu Huang is a Professor of Department of Environmental Medicine and Biochemistry and Molecular Pharmacology and Urology, and Deputy Director of Nelson Institute of Environmental medicine, New York University School of Medicine. Dr. Huang has published more than 280 research papers with total citations over 11,200. Chuanshu’s major research addresses fundamental questions concerning the responses of mammalian cells to environmental carcinogens at the levels of protein kinases, transcription factors and their target genes, as well as protein modification both in vitro and in vivo. His research also includes elucidation of tumor invasion and metastasis, as well as screening and identifying novel anti-cancer drugs and the molecular mechanisms underlying their anti-cancer effect.
Mohammad A. Kamal King Fahd Medical Research Center King Abdulaziz University Jeddah Saudi Arabia Biography
Biography of Mohammad A. Kamal
Prof. Dr. Mohammad Amjad Kamal is a Distinguished Adjunct
Professor at the King Fahd Medical Research Center (KFMRC),
King Abdulaziz University, Saudi Arabia, where he was full
Professor from March 2011 to March 2013. He is leading a
highly productive global collaborative research team based from
Novel Global Community Educational Foundation (NGCEF),
Australia. Dr. Kamal's biochemical research in the field of
Alzheimer’s disease, Type 2 diabetes and leukemia has
culminated in more than 500 publications in internationally
respected journals, and 65 abstracts at international conferences.
Prof. Kamal migrated to Australia in 1998 and was awarded a
prestigious U2000 Postdoctoral Fellowship in 2000 by the
University of Sydney, School of Molecular and Microbial Biosciences. Moreover, he is serving
as a regional/editorial member/guest editor of several reputed scientific journals - this is
undertaken on an honorable basis.
J. Kuroda Division of Hematology and Oncology, Department of Medicine Kyoto Prefectural University of Medicine Japan Biography
Biography of J. Kuroda
Junya Kuroda, holder of M.D. and Ph.D. degrees, is an associate professor at the Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine in Kyoto, Japan, and has published more than 120 articles.
Junya Kuroda’s research interests focused on the identification of the disease–specific dysregulation of epigenetics, genetics, cytogenetics, and cell signaling, to develop novel therapeutic strategies and biomarkers for cancers, especially hematologic malignancies, such as leukemias, lymphomas, or myeloma, while also covers clinical researches in hematological oncology.
Juan C. Lacal CSIC (Spanish Research Council) Instituto de Investigaciones Biomédicas Madrid Spain
rajkumar Lakshmanaswamy Texas Tech University Health Sciences Center at El Paso Texas, TX USA
Shuibin Lin First Affiliated Hospital Sun Yat-sen University Guangzhou China Biography
Biography of Shuibin Lin
Dr. Lin is currently a Principal Investigator/Professor at the First Affiliated
Hospital in Sun Yat-sen University, Guangzhou, China. His lab works on RNA
modifications, cancers and stem cells related diseases.
Jing-Yuan Liu Indiana University-Purdue University at Indianapolis Indianapolis, IN USA
Philippe Marchetti French Institute of Health and Medical Research University of Lille Lille France
Debabrata Mukhopadhyay Department of Biochemistry and Molecular Biology, and Department of Biomedical Engineering Mayo Clinic Cancer Center, Mayo Clinic Rochester, MN USA Biography
Biography of Debabrata Mukhopadhyay
Debabrata (Dev) Mukhopadhyay, Ph.D.: Professor of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Jacksonville, Florida, has a joint appointment with the Department of Physiology and Biomedical Engineering. Before moving to Mayo Clinic as Professor 14 years ago, he was research fellow and later independent investigator followed by as an Associate Professor at Harvard Medical School, Boston. He has carried out angiogenesis and tumor microenvironment related research and also leading translational nanomedicine programs including new drug delivery systems. He has been serving as reviewer for several study sections in NIH and agencies. Recently, he has been appointed as the Florida Department of Health Cancer Research Chair. He has published more than 190 peer-reviewed papers in different journals including Nature, Nature Medicine, Cancer Cell, Cancer Research, Nano Letters. He has several patents and has been involved to develop different start up companies in the area of therapy and diagnosis of the disease
Rakesh Naidu Jeffrey Cheah School of Medicine and Health Sciences Monash University Malaysia Selangor Darul Ehsan Malaysia Biography
Biography of Rakesh Naidu
Dr. Rakesh Naidu has been appointed as an Associate Professor in biomedical sciences at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. His current research focuses on the molecular biology of cancer, cancer therapeutics and cancer venomics. His research group focuses on the identification and understanding of the underlying molecular mechanisms of synthetic compounds and analogues derived from natural compounds as well as natural components from venoms that contribute to anti-cancer activities in human cancer cells such as lung, prostate, colon, breast and glioblastoma. He has published peer-reviewed research papers in several international and national journals and book chapters in cancer.
Vincent C.O. Njar Dept. of Pharmacology-Head, Medicinal Chemistry Section University of Maryland School of Medicine Baltimore, MD USA
Franco Patrone Department of Hemato-Oncology University of Genova Genova Italy Biography
Biography of Franco Patrone
Dr. Franco Patrone MD obtained specialization degrees in General Medicine, Hematology, and Oncology from the University of Genova, Italy. Currently Dr. Patrone is an adjunct professor of Internal Medicine in the Department of Internal Medicine, University of Genova. He has published more than 170 scientific publications reported on PubMed. Dr. Patrone has been, director of the first Medical Clinic and of the Department of Internal Medicine, University of Genoa, as well as of the Internal Medicine and Oncology Clinic and of the Department of Hematology and Oncology, San Martino University Hospital, Genoa, Italy.
Yves Pommier Division of Basic Sciences, NCI National Cancer Institute Bethesda, MD USA Biography
Biography of Yves Pommier
Yves Pommier is the Chief of the Developmental Therapeutics Branch, NCI. He obtained his M.D. and Ph.D. from the University of Paris, and has studied DNA topoisomerases and the pharmacology of their inhibitors for the past 30 years. Three of his topoisomerase I inhibitors are in clinical trials. Dr. Pommier also discovered the first HIV-1 integrase inhibitors and the mechanism of action of poly(ADPribose) polymerase inhibitors by trapping PARP-DNA complexes. He pioneered the concept of drugs acting as interfacial inhibitors.
Ennio Prosperi Istituto di Genetica Molecolare “Luigi Luca Cavalli-Sforza” CNR, Istituto di Genetica Molecolare Pavia Italy Biography
Biography of Ennio Prosperi
Dr. Prosperi graduated in Biological Sciences at the University of Pavia (Italy) and performed PhD studies in Physiological Sciences at the University of Milano, and in the Histochemistry Dept. of Leiden University” (Nederland). Dr. Prosperi is a Senior Researcher in the Institute of Molecular Genetics of the Italian National Research Council (CNR), lab of Genome Stability and DNA damage response, with more than 100 publications. Formerly, Lecturer in Physiopathology of the Cell Cycle, in the Medical Faculty of Pavia University, Dr. Prosperi is currently a teacher in the PhD program in “Genetics, Molecular and Cellular Biology” (Pavia University).
Balazs Sarkadi Biomembrane Laboratory Natural Sciences Research Center National Medical Center Budapest Hungary Biography
Biography of Balazs Sarkadi
Balázs Sarkadi, MD, Ph.D., spent several years as a post-doc and then as a visiting scientist at major universities in the United States and Canada. He is research professor at Semmelweis University, member of the Hungarian Academy of Sciences, past president of FEBS, member of several international research societies including the Academia Europeae. His research has been focusing on membrane proteins, including the investigation of ABC membrane transporters, which play a major role in the multidrug resistance of cancer, in general pharmacology, and in stem cell function. He has published more than 250 papers in international scientific journals, with a citation number over 13,000.
Stefania Scala Oncological Immunology National Cancer Institute "G. Pascale" Naples Italy
Kedong Song Dalian R&D Centre for Stem Cells and Tissue Engineering, State Key Lab of Fine Chemicals Dalian University of Technology Dalian China Biography
Biography of Kedong Song
Dr. Kedong Song is currently Professor in Dalian R&D Centre for Stem Cells and Tissue
Engineering, State Key Lab of Fine Chemicals, Dalian University of Technology. Prof.
Song obtained a PhD degree from Dalian University of Technology. He was a
Post‐doctoral research associate in Department of Chemical Engineering, Imperial
College London from 2008 to 2009. He became a full professor in 2016 at Dalian
University of Technology in the areas of 3D tumor models, Stem Cells, Tissue
Engineering and Pharmaceutical Chemistry. Prof. Song has published over 100 papers
on international journals, and has got citation more than 2,500 times.
Kalkunte S. Srivenugopal Department of Biomedical Sciences Texas Tech University Health Sciences Center Amarillo, Texas USA Biography
Biography of Kalkunte S. Srivenugopal
Dr. Kalkunte Srivenugopal obtained his Ph.D. in Biochemistry From the Indian Institute of Science. He is currently a tenured Professor of Biomedical Sciences at the Texas Tech University School of Pharmacy in Amarillo, Texas, USA. Dr. Srivenugopal’s research interests include brain tumor chemotherapy, DNA repair, drug discovery, p53 biology and redox signaling. He has received funding from the National Institutes of Health, Cancer Prevention Research Institute of Texas and many private foundations. He has published more than 85 peer-reviewed articles.
George S.W. Tsao Department of Anatomy, Faculty of Medicine University of Hong Kong Pok Fu Lam Hong Kong
Wei Wang School of Pharmacy Hunan University of Chinese Medicine Hunan China
Yingqiu Xie Department of Biology Nazarbayev University Astana Kazakhstan Biography
Biography of Yingqiu Xie
Yingqiu Xie is an Associate Professor of Biology. He received a Ph.D.
in genetics. Dr. Xie’s research interests include cancer drug targets, cell
signaling, biomarkers, cancer genetics, cancer recurrence, drug
resistance and experimental therapeutics, especially in prostate cancer
and leukemia. Recently Dr. Xie has carried out the research on
nanotechnology and herbal medicine in cancer signaling and
pharmacology. Dr. Xie has been qualified for Ph.D. supervisor and has
been a supervisor of several M.S. students. He has been serving as
reviewer and Editorial Board member for several journals.
Lin Zhang Department of Pharmacology & Chemical Biology University of Pittsburgh Pittsburgh, PA USA
Associate Editorial Board Members
Kenneth S. Hettie Department of Radiology Stanford University School of Medicine Stanford, CA USA Biography
Biography of Kenneth S. Hettie
Dr. Hettie is an NCI/NIH Ruth L. Kirschstein NRSA Fellow (PI/PD) in the Departments of Radiology and Otolaryngology-Head & Neck Surgery within the School of Medicine at Stanford University that specializes in the design, development, and implementation of near-infrared-I/II peptidyl-, nucleic acid-, and immuno-based activatable bio-/molecular probes, biosensors, theranostics, and nanoparticles targeting biomarkers of brain cancers and their tumor microenvironment for their early detection, direct visualization, and surgical removal via utilizing image-guided surgery. He focuses on their rational design, bio-/chemical synthesis, and bio-/analytical evaluation of novel diagnostics and therapeutics in basic science research, preclinical, and clinical setting.
Weiwei Wang Geneis (Beijing) Co., Ltd Beijing China Biography
Biography of Weiwei Wang
Dr. Weiwei Wang received his Doctoral degree from Beijing institute of Genomics, Chinese Academy of Sciences. He finished his post-doctoral training and worked as a research associate at the University of Alberta in Canada. Currently he is serving as a CTO, Vice President, R&D Director in Geneis (Beijing) Co. His main research areas are IVD assay development/related translational studies including cancer related ctDNA/cfRNA identification using NGS/nanopore sequencing; clinical metagenomics; virome enrichment and sequencing; single-cell multi-omics; microfluidic-chip based assays. Dr. Wang has published more than 30 peer-reviewed papers/book chapters in the journals related to oncology, virology, immunology, metagenomics, genomics, proteomics, etc.
Nathaniel Weygant Academy of Integrative Medicine Fujian University of Traditional Chinese Medicine Fuzhou China Biography
Biography of Nathaniel Weygant
Dr. Nathaniel Weygant is a Professor at Fujian University of Traditional Chinese Medicine. His interests include investigating the role of epithelial-immune crosstalk in cancer, identifying subpopulations of cancer patients vulnerable to cancer progression, understanding gender differences in cancer and identifying therapies to target CSCs. His previous work included investigating the functional role of the DCLK1 CSC marker, role of intestinal epithelia in the inflammatory response, the development of miRNA/mRNA oncology biomarkers and the development of therapeutic monoclonal antibodies. Dr. Weygant performed his undergraduate studies at the University of Oklahoma (Oklahoma, USA) and obtained his PhD from the University of Portsmouth (Portsmouth, UK).
Executive Guest Editor(s)
Manny D. Bacolod Department of Microbiology and Immunology Weill Cornell Medical College New York, NY USA Biography
Biography of Manny D. Bacolod
Dr. Manny D. Bacolod is currently an Assistant Professor of Microbiology and Immunology at Weill
Cornell Medical College (New York, NY). After earning his Ph.D. in Chemistry from the University of
Connecticut, he has held various research positions at Duke University Medical Center, Weill Cornell
Medical College, Brigham and Women’s Hospital, and Virginia Commonwealth University. Dr.
Bacolod’s contribution to cancer literature encompasses a wide range of topics including colon cancer
genomics and biomarker discovery, epigenetics, cancer genetics, brain tumor drug resistance, chemical
mutagenesis, cancer metastasis, and immuno oncogenomics.
Yonghan He Kunming Institute of Zoology Kunming Institute of Zoology, Chinese Academy of Sciences Kunming China Biography
Biography of Yonghan He
Dr. Yonghan He received his M.D. degree from Harbin Medical University in China. He finished his post-doctoral training at the University of Arkansas for Medical Sciences, and University of Florida in the USA. He is presently serving as an Associate professor of Kunming Institute of Zoology, Chinese Academy of Sciences. Dr. He focuses on studying the mechanisms involved in cancer cell death, and developing small molecules or natural compounds that suppress tumor cell growth. He is also very interested in studying cellular senescence and developing senolytics that can selectively kill senescent cells to improve the health of aged individuals. Dr. He has published more than 50 peer-reviewed papers in journals related to cancer or aging.
Heiko Konig Department of Hematology and Oncology Indiana University Melvin and Bren Simon Cancer Center Indianapolis, IN USA Biography
Biography of Heiko Konig
Dr. Heiko Konig is presently serving as an Assistant Professor at the Indiana University Melvin & Bren Simon Cancer Center in Inianapolis where his effort is dedicated to the care of patients with acute myeloid leukemia (AML) and other hematological malignancies, and laboratory based research with a focus on the role of hypoxia in the development of AML drug resistance and minimal residual disease. He received his MD and doctoral degrees from the medical schools at the Ludwig Maximilians University Munich and the Philipps University Marburg/ Germany, respectively. He is also serving as the co-chair of the Big Ten Cancer Research Consortium (BTCRC) Myeloid Malignancies Clinical Trial Working Group and the Hoosier Cancer Research Network (HCRN) Lymphoma/Leukemia Clinical Trial Working Group.
Guangwei Liu Institute of Cell Biology, College of Life Sciences Beijing Normal University Beijing China Biography
Biography of Guangwei Liu
Dr. Guangwei Liu is currently serving as a professor in the Key Laboratory of Cell Proliferation and Regulation, Ministry of Education, Beijing Normal University, Beijing, China. He and his group members are currently interested in understanding the molecular and cellular mechanisms for positive and negative regulation of T cell immune function, exploring the possibility for clinical application of anti-tumor immunotherapy and anti-infection, as well as establishing protocols to induce transplant immune tolerance. He has contributed more than 70 peer reviewed papers in international journals such as Immunity, Nature Immunology, Nature Communications, PNAS, Blood, Journal of Immunology and Cancer Research.
Valery V. Tuchin Institute of Precision Mechanics and Control of the RAS Saratov State University Saratov Russia Biography
Biography of Valery V. Tuchin
Dr. Valery V. Tuchin is presently serving as a Professor and Chair of Optics and Biophotonics at Saratov University (National Research University of Russia). He is also the head of Laboratory of Laser Diagnostics of Technical and Living Systems, Institute of Precision Mechanics and Control, RAS, and the supervisor of Interdisciplinary Laboratory of Biophotonics at Tomsk State University (National Research University of Russia) and Laboratory of FemtoMedicine of ITMO University (National Research University of Russia). His research interests include tissue optics, laser medicine, tissue optical clearing, and nanobiophotonics. He has published more than 700 papers (Web of Science), 27 monographs and text-books, and 58 book chapters. Dr. Tuchin is also a holder of more than 50 patents.